ALVRANT Trademark

Trademark Overview


On Thursday, May 16, 2019, a trademark application was filed for ALVRANT with the United States Patent and Trademark Office. The USPTO has given the ALVRANT trademark a serial number of 79263055. The federal status of this trademark filing is REGISTERED as of Tuesday, November 26, 2019. This trademark is owned by Glaxo Group Limited. The ALVRANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
alvrant

General Information


Serial Number79263055
Word MarkALVRANT
Filing DateThursday, May 16, 2019
Status700 - REGISTERED
Status DateTuesday, November 26, 2019
Registration Number5917460
Registration DateTuesday, November 26, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 31, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Friday, February 7, 2020NOTIFICATION PROCESSED BY IB
Thursday, January 23, 2020FINAL DISPOSITION NOTICE SENT TO IB
Thursday, January 23, 2020FINAL DISPOSITION PROCESSED
Thursday, December 26, 2019GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, November 26, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, September 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 21, 2019NOTICE OF PUBLICATION
Tuesday, August 6, 2019APPLICATION FILING RECEIPT MAILED
Monday, August 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 1, 2019ASSIGNED TO EXAMINER
Wednesday, July 31, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 25, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 18, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB